Compensation 990
OrganizationsEmployeesBoard MembersGrantsContractorsTop RankingsPricing

Stay updated on 990 organization compensation

© Civic Register LLC

Compensation 990 is an independent service that uses public IRS Form 990 filings as its source data. We clean and standardize this information, but the original filings may contain errors or omissions. Years on this site refer to the organization’s fiscal year end date on the filing.

About•Report a discrepancy•Your privacy choices
Employees International Society for Cns Drug Development Amir Kalali

Amir Kalali

OfficerTrustee/director

Chief Financial Officer and Secretary at International Society for Cns Drug Development

Fiscal year ended December 31, 2024. Published on January 25, 2026.

$127,000
2024

Total compensation

Amir Kalali has been listed as an employee of International Society for Cns Drug Development in Form 990 filings since fiscal year 2020. Total compensation for Amir Kalali has increased by 33.7% from 2020 to 2024.

Annual compensation details

$127,000
±0%
Chief Financial Officer and Secretary
2024
$127k
20 hrs/wk
$127,000
+0.1%
Chief Financial Officer and Secretary
2023
$127k
20 hrs/wk
$126,856
+5.7%
Chief Financial Officer and Secretary
2022
$127k
20 hrs/wk
$120,000
+26.3%
Chief Financial Officer and Secretary
2021
$120k
20 hrs/wk
$95,000
Chief Financial Officer and Secretary
2020
$95k
20 hrs/wk

Total compensation by year

Compare the compensation of Amir Kalali to:

Loading related profiles…

Revisions to this profile

January 25, 2026:
2024 International Society for Cns Drug Development 990 published
January 25, 2026:
2023 International Society for Cns Drug Development 990 published
January 25, 2026:
2022 International Society for Cns Drug Development 990 published

Get an email update when compensation for Amir Kalali is updated

Related Jobs

View more jobs
Powered by Talroo
Report a discrepancy →

Other people named Amir Kalali

2024
Employee
Amir Kalali
Decentralized Trials & Research Alliance
$513,687
Board Member
Amir Kalali
International Society for Cns Clinical Trial
$0